Scorpion Therapeutics has secured $150m in a Series C financing round to progres...
China’s NMPA has granted approval for Zai Lab and argenx's efgartigimod SC for t...
The US FDA has issued a complete response letter (CRL) to Orexo regarding its ND...
Approval of tabelecleucel would mark the first available therapy for the treatme...
AstraZeneca has obtained Health Canada’s Notice of Compliance (NOC) for Tagrisso...
The company will initiate Phase Ib and Phase II studies in major depression in 2...
AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment...
Global vaccine coverage is yet to return to levels seen in 2019, shortly before ...
Nona Biosciences has partnered with biotechnology company Alaya.bio to work on a...
Australia is fast becoming the place to be for innovative life sciences companie...
AusperBio has raised $37m in a Series A financing round to progress the clinical...
The US Food and Drug Administration (FDA) has granted fast track designation to ...
MSD (Merck & Co) plans to start a Phase IIb/III trial for EyeBio’s lead candidat...
As Wes Streeting takes over the UK’s Department for Health and Social care, inve...
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital tr...
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech ...
